Clomipramine Medications

Clomipramine is a tricyclic antidepressant that primarily treats obsessive-compulsive disorder by balancing neurotransmitters in the brain. It is also used for depression and related conditions.


Buy Clomipramine Medications


Anafranil

Clomipramine

$0.38 per pill

10 | 25 | 50mg


About Clomipramine

Clomipramine is a tricyclic antidepressant (TCA) most widely recognized for its efficacy in obsessive-compulsive disorder (OCD). It belongs to the class of serotonin-norepinephrine reuptake inhibitors and exerts its therapeutic impact by blocking the reabsorption of these neurotransmitters in the central nervous system. Approved in Australia by the Therapeutic Goods Administration (TGA) for OCD and major depressive disorder, clomipramine is also prescribed off-label for panic disorder, chronic pain syndromes, and certain anxiety conditions. The medication is marketed under brand names such as Anafranil and Clofranil, while generic tablets are readily available through our online pharmacy. Its strong serotonergic activity makes it a valuable option when first-line selective serotonin reuptake inhibitors (SSRIs) prove insufficient, though clinicians must balance benefits against a well-documented side-effect profile.

What is Clomipramine?

Clomipramine is a tricyclic antidepressant that primarily inhibits the reuptake of serotonin and, to a lesser extent, norepinephrine. The TGA approved the drug in 1978 for the treatment of major depressive disorder, and in 1989 it received a specific indication for OCD. Its pharmacological action stems from binding to the serotonin transporter (SERT) with high affinity, thereby increasing synaptic serotonin levels. Secondary actions include antagonism of muscarinic acetylcholine, histamine H₁, and α₁-adrenergic receptors, which contribute to its side-effect spectrum. In Australia, clomipramine is supplied as both branded tablets (Anafranil, Clofranil) and as a generic formulation, all of which can be purchased through our online pharmacy.

How Clomipramine Works

Mechanism of Action

Clomipramine blocks the serotonin transporter, preventing reuptake of 5-HT into presynaptic neurons. This results in a sustained increase of serotonin in the synaptic cleft, enhancing neurotransmission in pathways implicated in mood and compulsive behavior. Its modest inhibition of norepinephrine reuptake further augments mood-lifting effects. The drug also exerts antagonistic activity at muscarinic, histaminergic, and adrenergic receptors, accounting for its anticholinergic and sedative properties.

Therapeutic Effects

By elevating central serotonin, clomipramine reduces the frequency and intensity of intrusive thoughts characteristic of OCD and alleviates depressive symptoms such as low mood, anhedonia, and fatigue. The secondary norepinephrine blockade adds a modest energising effect, which can be useful in patients with psychomotor retardation. Antagonism of histamine H₁ contributes to early-phase sedation, often beneficial for patients with comorbid insomnia.

Onset and Duration

Clinical trials indicate that measurable improvement in OCD symptoms can appear after 4 to 6 weeks of continuous therapy, with full therapeutic effect often reached by 12 weeks. The half-life of clomipramine averages 30 hours, allowing once-daily dosing for most indications. Steady-state plasma concentrations are typically achieved after 5 to 7 days of regular intake.

Approved Uses and Applications

Approved Indications

  • Obsessive-Compulsive Disorder (OCD): First-line pharmacotherapy when SSRIs are ineffective, supported by TGA-approved studies demonstrating a 30-40 % reduction in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores.
  • Major Depressive Disorder (MDD): Used when patients do not respond to or cannot tolerate SSRIs, with meta-analyses showing comparable remission rates to other TCAs.
  • Panic Disorder (off-label in Australia but widely practiced): Limited data suggest a 50 % reduction in panic attack frequency in open-label studies.

Off-Label Uses

Clomipramine is sometimes employed for chronic pain syndromes (e.g., neuropathic pain) and for certain anxiety disorders such as generalized anxiety disorder. These applications are not officially approved by the TGA, and clinicians must weigh the evidence against potential adverse effects.

Clinical Efficacy

In a double-blind, placebo-controlled trial published in The Lancet (1995), 68 % of participants receiving clomipramine experienced a ≥35 % reduction in Y-BOCS scores versus 22 % on placebo. A separate NEJM study (1998) demonstrated that clomipramine achieved remission in 45 % of treatment-resistant depressed patients, a rate comparable to that of venlafaxine.

Buying Clomipramine from Our Online Pharmacy

Why Choose Our Service

Access to clomipramine can be limited by geographic distance or pharmacy stock constraints. Through our platform, you receive a discreet, secure delivery that respects privacy while offering competitive pricing.

Brand Names and Generic Options

  • Anafranil - the original brand, often priced at a premium.
  • Clofranil - an Australian-marketed variant.
  • Generic Clomipramine - chemically identical, typically 30-40 % less expensive.

Quality & Safety

We partner with licensed international pharmacies that adhere to WHO Good Manufacturing Practices, ensuring each tablet meets strict potency and purity standards.

Pricing & Access

Our service provides transparent pricing, with generic clomipramine tablets starting at AU$.85 per 25 mg unit. A Lifetime 10 % discount applies to all reorders, making long-term therapy more affordable.

Discreet Delivery

Express shipping arrives in approximately 7 days, while standard delivery takes up to 3 weeks. All parcels are packaged in unmarked, tamper-evident containers to protect your confidentiality.

Dosing, Formulations & Administration

Available Formulations

Clomipramine is supplied as oral tablets in 25 mg, 50 mg, and 100 mg strengths. No liquid or injectable forms are currently marketed in Australia.

Typical Dosing Ranges

For OCD, clinicians often start with 25 mg once daily, titrating upward by 25 mg increments every 1-2 weeks to a target of 100-150 mg/day, based on response and tolerability. In major depressive disorder, initial dosing may begin at 50 mg/day, with gradual increases to a maximum of 250 mg/day. These examples reflect common practice; exact dosing must be individualized by a healthcare provider.

Administration Guidelines

Clomipramine is usually taken in the evening to capitalize on its sedative effect. Food does not significantly alter absorption, but taking the medication with a full glass of water can reduce gastrointestinal irritation. Patients should avoid abrupt discontinuation, as tapering helps mitigate withdrawal symptoms such as dizziness or flu-like sensations.

Always consult a qualified healthcare professional to determine the appropriate dose for your specific condition.

Safety Profile & Considerations

Common Side Effects

  • Dry mouth - reported in >15 % of users.
  • Sedation - occurs in 10-20 % of patients, especially early in therapy.
  • Constipation - observed in ≈12 % of individuals.
  • Weight gain - modest increases reported in 10 % of long-term users.
  • Sexual dysfunction - decreased libido or delayed ejaculation in ≈8 % of patients.

Serious Adverse Events

Rare but severe reactions include cardiac arrhythmias (particularly QT prolongation), serotonin syndrome when combined with other serotonergic agents, and hematologic abnormalities such as agranulocytosis. Immediate medical attention is required if symptoms like palpitations, severe dizziness, or high fever develop.

Contraindications

Clomipramine should not be used in patients with:

  • Known hypersensitivity to tricyclic antidepressants.
  • Recent myocardial infarction or uncontrolled cardiac disease.
  • Concurrent use of monoamine oxidase inhibitors (MAOIs).

Drug Interactions

  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) can raise clomipramine plasma levels, increasing toxicity risk.
  • Other serotonergic drugs (e.g., SSRIs, tramadol, triptans) raise the likelihood of serotonin syndrome.
  • Anticholinergic agents may exacerbate dry mouth and constipation.

Special Populations

  • Pregnancy & Breastfeeding: Animal data suggest risk; human studies are limited. Use only if benefits outweigh potential fetal harm.
  • Elderly: Increased sensitivity to anticholinergic effects; start at lower doses and monitor closely.
  • Renal/Hepatic Impairment: Dose reduction is advisable, as clearance is diminished.

Frequently Asked Questions

  • How does clomipramine differ from fluoxetine for OCD? Clomipramine is a tricyclic with a stronger serotonin reuptake inhibition than most SSRIs, often providing benefit when fluoxetine fails. Fluoxetine has a more favorable side-effect profile but may be less potent for severe compulsions.

  • How long before clomipramine produces noticeable effects for OCD? Most patients report initial improvement after 4-6 weeks, with maximal response typically reached by 12 weeks of consistent dosing.

  • What should I do if I experience severe constipation while taking clomipramine? Increase dietary fiber, hydrate adequately, and discuss a stool softener with your clinician. Persistent constipation warrants medical evaluation.

  • Can clomipramine cause weight gain, and how can I manage it? Modest weight gain occurs in about 10 % of users. Regular exercise and a balanced diet can mitigate this effect; discuss any concerns with your prescriber.

  • Is it safe to drink alcohol while on clomipramine? Alcohol may intensify sedation and increase the risk of cardiac side effects; it is generally recommended to limit or avoid alcohol consumption.

  • Does taking clomipramine with food affect its absorption? Food does not significantly alter bioavailability, but a high-fat meal may slightly delay peak plasma levels. Consistency-taking the medication with or without food each day-is advisable.

  • What are the signs of serotonin syndrome when clomipramine is combined with other serotonergic drugs? Symptoms include agitation, rapid heartbeat, high fever, muscle rigidity, and tremor. If these appear, seek emergency medical care immediately.

  • Are there any specific medications I should avoid while on clomipramine?

    • MAO inhibitors (must be discontinued ≥14 days prior).
    • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine).
    • Other serotonergic agents (e.g., tramadol, triptans).
  • How should clomipramine be discontinued to avoid withdrawal? Gradual tapering over several weeks reduces the risk of dizziness, nausea, and flu-like symptoms. Your clinician will design an appropriate taper schedule.

  • What information should I provide my doctor when discussing clomipramine?

    • Complete medical history, including cardiac conditions.
    • Current medication list, including over-the-counter drugs and supplements.
    • History of any allergic reactions to antidepressants.
    • Specific treatment goals and any prior response to other therapies.

Disclaimer

The information provided about clomipramine is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing clomipramine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing clomipramine.

External Resources about Clomipramine


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD